These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28972956)

  • 1. Association between polycystic ovary syndrome and the risk of subclinical vascular disease in normal‑weight women with type 1 diabetes.
    Łebkowska A; Adamska A; Jacewicz M; Tołwińska J; Krentowska A; Hryniewicka J; Leśniewska M; Bossowski A; Górska M; Kowalska I
    Pol Arch Intern Med; 2017 Nov; 127(11):741-748. PubMed ID: 28972956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
    Tripathy P; Sahu A; Sahu M; Nagy A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
    Łebkowska A; Adamska A; Krentowska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Hryniewicka J; Leśniewska M; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
    J Clin Endocrinol Metab; 2021 May; 106(6):1811-1820. PubMed ID: 33537700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome.
    Rashad NM; El-Shal AS; Abomandour HG; Aboelfath AMK; Rafeek MES; Badr MS; Ali AE; Yousef MS; Fathy MA; Sharaf El Din MTA
    J Ovarian Res; 2019 Oct; 12(1):97. PubMed ID: 31629408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
    Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
    Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.
    Celik C; Bastu E; Abali R; Alpsoy S; Guzel EC; Aydemir B; Yeh J
    Gynecol Endocrinol; 2013 May; 29(5):488-91. PubMed ID: 23480818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.
    Hughan KS; Tfayli H; Warren-Ulanch JG; Barinas-Mitchell E; Arslanian SA
    J Pediatr; 2016 Jan; 168():104-111.e1. PubMed ID: 26545724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome.
    Buyukkaya R; Besir FH; Yazgan S; Karatas A; Kose SA; Aydin Y; Erdogmus B
    Clin Ter; 2014; 165(1):e6-11. PubMed ID: 24589963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.
    Vipin VP; Dabadghao P; Shukla M; Kapoor A; Raghuvanshi AS; Ramesh V
    Fertil Steril; 2016 May; 105(5):1338-1344.e3. PubMed ID: 26852421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
    Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
    Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of thyroid autoimmunity with ovarian reserve in women with type 1 diabetes with and without polycystic ovary syndrome.
    Łebkowska A; Krentowska A; Adamska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Leśniewska M; Sowa P; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
    Sci Rep; 2024 Jun; 14(1):13223. PubMed ID: 38851814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome?
    Ramoglu S; Yoldemir T; Atasayan K; Yavuz DG
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1848-1854. PubMed ID: 28892255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE; Ilie IR; Marian I; Duncea I
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome.
    Abali R; Tasdemir N; Alpsoy S; Tasdemir UG; Guzel S; Yuksel MA; Temel Yuksel I; Yilmaz M
    Arch Gynecol Obstet; 2015 May; 291(5):1075-80. PubMed ID: 25280574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carotid artery intima-media thickness (cIMT) in young type 1 diabetic patients in relation to comorbid additional autoimmune diseases and microvascular complications].
    Klonowska B; Charemska D; Jabłońska J; Banach A; Kącka A; Szynkarczuk E; Konopka M; Jarocka-Cyrta E; Załuski D; Głowińska-Olszewska B
    Pediatr Endocrinol Diabetes Metab; 2016; 22(3):. PubMed ID: 28633159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is thyroid autoimmunity associated with subclinical atherosclerosis in young women with type 1 diabetes mellitus?
    Łukawska-Tatarczuk MM; Zieliński J; Franek E; Czupryniak L; Mrozikiewicz-Rakowska B
    Endokrynol Pol; 2022; 73(2):301-308. PubMed ID: 35381091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.